News
Garber Announces Advisory Committee for Harvard Law School Dean Search
News
First Harvard Prize Book in Kosovo Established by Harvard Alumni
News
Ryan Murdock ’25 Remembered as Dedicated Advocate and Caring Friend
News
Harvard Faculty Appeal Temporary Suspensions From Widener Library
News
Man Who Managed Clients for High-End Cambridge Brothel Network Pleads Guilty
With an immune system designed to destroy invading organisms, patients receiving organ transplants often run the risk of becoming their own worst enemies.
But by transferring some of the donor’s bone marrow along with the organs, two Medical School researchers have found a way to fool immune cells into accepting foreign tissue as well. Four of the five study’s subjects received successful transplants.
Researchers believe the new procedure, which begins with a partial destruction of the patient’s bone marrow using a drug, may decrease organ rejection. The bone marrow gives rise to immune cells that help the body identify invaders. If the foreign marrow produces foreign cells, the study’s authors hypothesized that the body will recognize the transplant as one of its own.
But the researchers, David H. Sachs and A. Benedict Cosimi, are looking beyond mere human transplants. They’ve already filed a patent for transplants from animals to humans.
For recent research, faculty profiles, and a look at the issues facing Harvard scientists, check out The Crimson's science page.
Want to keep up with breaking news? Subscribe to our email newsletter.